IPOGrid
0001814140
IPO filing research

Apexigen, Inc.

Pharmaceutical Preparations

follow-on priced 425

Apexigen, Inc. IPO research page with SEC filing history, offering status, deal terms, structured filing extracts, company news, and comparable IPO context. Latest filing: 425 on 2023-08-11.

Filing Timeline

SEC EDGAR
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2023-08-11 · 0000950170-23-041602
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2023-08-11 · 0000950170-23-041579
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2023-06-30 · 0000950170-23-031134
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2023-05-25 · 0000950170-23-024070
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2023-05-24 · 0001193125-23-152390
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2023-05-24 · 0000950170-23-023958
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 424B3 in the pre-IPO sequence.
2023-05-24 · 0000950170-23-023950
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2023-04-10 · 0001193125-23-096513
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2023-04-10 · 0001193125-23-096512
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2023-04-07 · 9999999995-23-000864
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2023-04-07 · 9999999995-23-000863
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2023-03-21 · 9999999995-23-000622
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows S-1/A and confirms the priced prospectus.
2023-03-21 · 0001193125-23-075788
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
2023-03-17 · 0001193125-23-073842
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 424B3 in the pre-IPO sequence.
2023-02-22 · 0001193125-23-044843
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2023-01-30 · 0000950170-23-001344
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2023-01-30 · 0000950170-23-001343
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows EFFECT and marks the registration effective.
2022-09-09 · 9999999995-22-002645
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 424B3 and marks the registration effective.
2022-09-09 · 9999999995-22-002644
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows 424B3 and confirms the priced prospectus.
2022-09-09 · 0001193125-22-242024
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows S-1/A and confirms the priced prospectus.
2022-09-09 · 0001193125-22-242018
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2022-09-01 · 0001193125-22-236626
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
2022-09-01 · 0001193125-22-236622
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows S-1 in the pre-IPO sequence.
2022-08-12 · 0001193125-22-220084
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows 425 in the pre-IPO sequence.
2022-08-12 · 0001193125-22-220082
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2022-07-18 · 0001193125-22-196378
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 424B3 in the pre-IPO sequence.
2022-07-11 · 0001193125-22-191359
424B3 priced
Final prospectus
Final prospectus filed near launch with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2022-07-06 · 0001193125-22-188598
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows 425 and marks the registration effective.
2022-07-05 · 9999999995-22-001963
S-4/A amended
S-4/A
Pre-IPO filing captured from the SEC submission timeline.
Updates the prior 425 filing.
2022-06-30 · 0001193125-22-186296
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows S-4/A in the pre-IPO sequence.
2022-06-30 · 0001193125-22-185567
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows S-4/A in the pre-IPO sequence.
2022-06-29 · 0001193125-22-185103
S-4/A amended
S-4/A
Pre-IPO filing captured from the SEC submission timeline.
Updates the prior 425 filing.
2022-06-27 · 0001193125-22-182827
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows S-4/A in the pre-IPO sequence.
2022-06-15 · 0001193125-22-173979
S-4/A amended
S-4/A
Pre-IPO filing captured from the SEC submission timeline.
Updates the prior 425 filing.
2022-06-14 · 0001193125-22-173941
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2022-06-08 · 0001193125-22-170296
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2022-06-03 · 0001193125-22-167415
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows S-4/A in the pre-IPO sequence.
2022-06-02 · 0001193125-22-166305
S-4/A amended
S-4/A
Pre-IPO filing captured from the SEC submission timeline.
Updates the prior 425 filing.
2022-05-24 · 0001193125-22-157687
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2022-05-19 · 0001193125-22-155181
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2022-05-16 · 0001193125-22-151720
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2022-05-09 · 0001193125-22-145109
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows S-4 in the pre-IPO sequence.
2022-04-22 · 0001193125-22-115223
S-4 filed
S-4
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2022-04-11 · 0001193125-22-100592
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 425 in the pre-IPO sequence.
2022-03-18 · 0001193125-22-079626
425 supplemental
425
Pre-IPO filing captured from the SEC submission timeline.
Follows 424B4 in the pre-IPO sequence.
2022-03-18 · 0001193125-22-078903
424B4 priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows EFFECT and confirms the priced prospectus.
2021-01-29 · 0001213900-21-005202
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows CERT and marks the registration effective.
2021-01-28 · 9999999995-21-000318
CERT inactive
CERT
Pre-IPO filing captured from the SEC submission timeline.
Follows S-1/A in the pre-IPO sequence.
2021-01-25 · 0001354457-21-000093
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior 8-A12B filing.
2021-01-07 · 0001213900-21-000934
8-A12B effective
Exchange Act registration
Registration filed to list the securities under the Exchange Act ahead of trading.
Follows S-1/A and registers the class of securities for exchange listing.
2020-09-03 · 0001213900-20-025142
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1/A filing.
2020-08-26 · 0001213900-20-023862
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
2020-08-24 · 0001213900-20-023306
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows DRS in the pre-IPO sequence.
2020-08-14 · 0001213900-20-022212
DRS filed
Draft registration statement
Draft registration filed confidentially before the public launch.
First tracked pre-IPO filing for this issuer.
2020-07-17 · 0001213900-20-017827
Comparable Deals

20 comparable deals

Healthcare & BiotechLast 18 months
Only 0 strict matches; expanded to 20 using nearest neighbors.
Showing top 8 by similarity.
+9.1%
Median day-1
60%
Above issue
+0.7%
Median week-1
-20.9%
Downside (p10)
BlossomHill Therapeutics, Inc. BLSM
2026-08-07 $150M Day 1: +0.0% Wk 1: +0.0%
same SICrecent IPO
Latigo Biotherapeutics, Inc. LTGO
2026-08-07 $346M Day 1: +1.4% Wk 1: +1.4%
same SICrecent IPO
Braveheart Bio, Inc. BRVE
2026-08-06 $383M Day 1: +65.6% Wk 1: +66.7%
same SICrecent IPO
Apnimed, Inc. APMD
2026-07-31 $192M Day 1: +43.6% Wk 1: +74.3%
same SICrecent IPO
Kardigan, Inc. KARD
2026-06-18 $400M Day 1: +37.5% Wk 1: +41.1%
same SICrecent IPO
Parabilis Medicines, Inc. PBLS
2026-06-10 $670M Day 1: +58.0% Wk 1: +30.2%
same SICrecent IPO
Seaport Therapeutics, Inc. SPTX
2026-05-01 $255M Day 1: +10.2% Wk 1: -13.9%
same SICrecent IPO
Avalyn Pharma Inc. AVLN
2026-04-30 $300M Day 1: +63.8% Wk 1: +53.9%
same SICrecent IPO

Recent News

No recent news stored for this issuer.